medtech
(197)
Johnson & Johnson left the medicine cabinet.
The name still evokes baby shampoo. The business now runs on cancer medicines, heart pumps and surgical technology. Its reinvention reveals the expensive work of turning scientific progress into everyday care.
BD and the power of small things
A syringe, a cabinet, a few centimeters of tubing. BD built a business around the details of care. Its next bet is that those details can talk to one another.
AdvaMed: The invention after the invention
A medical device can work perfectly and still struggle to reach a patient. AdvaMed organizes the companies trying to get through the other half of innovation: rules, reimbursement, and the politics of access.
Dash Technologies and the last mile of medicine
A medical device can do its job and still leave a hospital waiting. Dash Technologies builds the software that gets the result where it needs to go.
Definitive Healthcare maps the people behind the purchase
A hospital directory tells you where to knock. Definitive Healthcare tries to tell you whose door matters - and whether the trip is worth it.
Switzerland Innovation Park Basel Area sells scientists a head start
A biotech company can lose months before its first experiment. In the Basel Area, shared labs and room to grow turn the landlord into part of the research strategy.
Next4 Group wants to build the business before it writes the cheque
The Italian innovation holding has bought a venture builder and an AI specialist. Its bet: making a company ready for customers is part of making it ready for capital.
NEXT MANNHEIM knows what a startup needs next: a neighbour
A city-owned network gives founders specialised rooms, useful introductions and a route into industry. Its most revealing decision was to put a GreenTech ambition into a building it already had.
NEMIC helps medical ideas survive the expensive middle
A good medical idea can arrive years before a fundable business. In Providence, NEMIC works on the awkward interval between the two.
MatchPlay Wants Your Second Investor Meeting to Start Further Ahead
A pitch deck opens a conversation. MatchPlay is building a business around what comes next: checked facts, useful introductions, and a clearer route to capital.
Stratus Medical and the art of hitting a tiny nerve
A small expandable electrode is the centre of Stratus Medical’s chronic-pain business. Its story turns on a larger treatment zone, familiar equipment, and the surprisingly powerful role of an insurance policy.
Ajax Health builds the business around the breakthrough
A clever medical device still needs a route into the hospital. Ajax Health pairs small invention teams with big commercial engines - and makes the machinery of innovation its business.
The CRM That Followed the Patient Past the Sale
Servis.ai began as FreeAgent CRM. Its more interesting bet now is that healthcare's hardest work happens after a lead becomes a patient: referrals, visits, staffing, supplies, and the handoffs between them.
Gilmartin Group and the business of being believed
A healthcare breakthrough needs an investor who understands it. Gilmartin Group works on the awkward space between a company’s evidence, its promises, and the people writing the checks.
Accelpoint gets startups into the room where pilots happen
The Warsaw accelerator pairs public funding with corporate access. Its real test is whether a promising prototype can become something a bank, insurer or telecom will actually use.
DERBI Foundation and the hard part after the prototype
A medical device can work on a lab bench and still struggle to reach a hospital. Bengaluru’s DERBI Foundation helps founders tackle the testing, clinical connections and commercial decisions in between.
Global HealthX wants your startup to survive the hospital
A surgeon’s venture studio is tackling the awkward stretch between a promising healthcare product and a hospital that will actually use it. Its India market programme even makes room for a useful answer: no.
SmiLe gives biotech founders a lab - and lets them keep their equity
At Sweden’s SmiLe Venture Hub, shared laboratories come with business coaches, industry introductions and a patient timetable. The proposition is practical: spend less effort assembling the infrastructure, and more proving the business.
BOM is betting on fewer doors between an idea and a business
The Dutch public investor pairs venture capital with hands-on company building and international connections. Its latest move tackles a problem closer to home: a startup support system with too many moving parts.
At Dalhousie’s ideaHUB, the next business starts on a workbench
Hardware founders need somewhere to build, test and change their minds. Inside Dalhousie’s Emera ideaHUB, shared labs and engineering advice help turn promising research into physical products.
Lyonbiopôle works on biotech’s other problem: who opens the next door?
A promising discovery still needs partners, money and a route to patients. Lyonbiopôle has spent two decades organizing those introductions - and its new strategy puts the business end of science under the microscope.
H7 BioCapital starts with the buyer
The healthcare investor puts licensing and acquisition demand near the start of the startup journey. Its accelerator, angel syndicate and conference circuit turn that thesis into introductions, coaching and deal-by-deal investment.
Haley Chute Is Building Healthcare AI Around Its Scarcest Ingredient: Trust
The biomedical engineer turned product-and-marketing chief has a plain test for clinical AI: help people see what matters, keep the clinician in charge, and earn trust one conversation at a time.
Matt Kaufman Learned the Rules - Then Built a Career Making Complicated Things Clear
A lawyer by training and a builder by temperament, Matt Kaufman has spent two decades translating regulated, technical businesses into stories people can understand - and teams can act on.
Brian Katzman Made Lost Keys Obvious. Now He’s Making Compliance Legible.
A career that began with AdWords and helped turn Tile into a household shorthand now faces a less cuddly brief: explain why the paperwork around safety-critical software should move as quickly as the code.
Garrett Schwab Is Building for the Long Wait Between Idea and Impact
The XII Medical CEO has spent a career in the unglamorous middle of medical invention - where patents, payment, teams and patient access must eventually agree.
Michael Favet Keeps Choosing the Hard Part of Medtech
After helping take NeuroPace public, the engineer-turned-operator returned to a small clinical-stage company. His career makes a case for learning every room before taking the corner office.
Karun Naga Left Patent Law to Build What the Patents Promised
His route from Michigan engineering classrooms to a $130 million clinical-stage company is a study in useful detours, patient capital and the discipline to stop doing everything at once.
Nitin Salunke’s One-Risk-at-a-Time Playbook
The Supira Medical CEO built his career by translating biomechanics into products, then learned to run a startup by staging risk, keeping options open and making clinical data do the talking.
Mary Beth Moynihan Built a Career by Working Backward
For nearly three decades at Boston Scientific, Mary Beth Moynihan has treated a career less like a ladder than a design problem: name the destination, map the missing experiences and make the next move count.